

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 7.00312266 |
| 2 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.92361330 |
| 3 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.37754034 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 4.20280235 |
| 5 | deoxyribose phosphate biosynthetic process (GO:0046385) | 4.17702518 |
| 6 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 4.17702518 |
| 7 | nucleotide salvage (GO:0043173) | 4.15510454 |
| 8 | protein maturation by protein folding (GO:0022417) | 4.10659357 |
| 9 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 4.07414472 |
| 10 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.01322490 |
| 11 | base-excision repair, AP site formation (GO:0006285) | 3.97475764 |
| 12 | pentose-phosphate shunt (GO:0006098) | 3.96074821 |
| 13 | deoxyribonucleotide catabolic process (GO:0009264) | 3.85646490 |
| 14 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.81911306 |
| 15 | viral transcription (GO:0019083) | 3.77407194 |
| 16 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.76619748 |
| 17 | protein retention in ER lumen (GO:0006621) | 3.76352910 |
| 18 | deoxyribose phosphate catabolic process (GO:0046386) | 3.74599001 |
| 19 | GTP biosynthetic process (GO:0006183) | 3.73662136 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 3.70302551 |
| 21 | proline biosynthetic process (GO:0006561) | 3.63362246 |
| 22 | UTP biosynthetic process (GO:0006228) | 3.61477326 |
| 23 | CTP biosynthetic process (GO:0006241) | 3.61358117 |
| 24 | CTP metabolic process (GO:0046036) | 3.61358117 |
| 25 | purine nucleotide salvage (GO:0032261) | 3.58780575 |
| 26 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.53241533 |
| 27 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.52128963 |
| 28 | translational termination (GO:0006415) | 3.51199667 |
| 29 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.51137212 |
| 30 | oxidative phosphorylation (GO:0006119) | 3.50367914 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.48607044 |
| 32 | Golgi transport vesicle coating (GO:0048200) | 3.48607044 |
| 33 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.46997769 |
| 34 | glucose catabolic process (GO:0006007) | 3.46421431 |
| 35 | pentose metabolic process (GO:0019321) | 3.45307405 |
| 36 | negative regulation of B cell apoptotic process (GO:0002903) | 3.44232221 |
| 37 | metallo-sulfur cluster assembly (GO:0031163) | 3.43736410 |
| 38 | iron-sulfur cluster assembly (GO:0016226) | 3.43736410 |
| 39 | UTP metabolic process (GO:0046051) | 3.42902562 |
| 40 | mitochondrial calcium ion transport (GO:0006851) | 3.41000356 |
| 41 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.39988327 |
| 42 | regulation of mitochondrial translation (GO:0070129) | 3.39888303 |
| 43 | galactose catabolic process (GO:0019388) | 3.39442338 |
| 44 | NADPH regeneration (GO:0006740) | 3.38808564 |
| 45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.37781207 |
| 46 | translational elongation (GO:0006414) | 3.32350965 |
| 47 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.31940976 |
| 48 | pyrimidine nucleoside salvage (GO:0043097) | 3.31827356 |
| 49 | pyrimidine-containing compound salvage (GO:0008655) | 3.31827356 |
| 50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.30559869 |
| 51 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.27377302 |
| 52 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.26885399 |
| 53 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.26378672 |
| 54 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.26047463 |
| 55 | DNA strand elongation (GO:0022616) | 3.25727570 |
| 56 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.25158229 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.24325783 |
| 58 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 3.21835400 |
| 59 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.19706783 |
| 60 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.19706783 |
| 61 | ribosomal small subunit biogenesis (GO:0042274) | 3.19179764 |
| 62 | nucleoside salvage (GO:0043174) | 3.17254823 |
| 63 | protein localization to endoplasmic reticulum (GO:0070972) | 3.13512531 |
| 64 | cotranslational protein targeting to membrane (GO:0006613) | 3.13472346 |
| 65 | protein targeting to ER (GO:0045047) | 3.12568663 |
| 66 | deoxyribose phosphate metabolic process (GO:0019692) | 3.12499067 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.12284922 |
| 68 | L-phenylalanine metabolic process (GO:0006558) | 3.12284922 |
| 69 | NADH metabolic process (GO:0006734) | 3.11292049 |
| 70 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.11188584 |
| 71 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 3.04779066 |
| 72 | UV protection (GO:0009650) | 3.00042931 |
| 73 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.99808347 |
| 74 | viral life cycle (GO:0019058) | 2.98096302 |
| 75 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97541549 |
| 76 | DNA unwinding involved in DNA replication (GO:0006268) | 2.96691463 |
| 77 | deoxyribonucleotide metabolic process (GO:0009262) | 2.94496158 |
| 78 | pyrimidine nucleotide metabolic process (GO:0006220) | 2.92276430 |
| 79 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.90079546 |
| 80 | pyrimidine-containing compound biosynthetic process (GO:0072528) | 2.83878590 |
| 81 | cellular protein complex disassembly (GO:0043624) | 2.79880595 |
| 82 | cellular metabolic compound salvage (GO:0043094) | 2.79648372 |
| 83 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.79400861 |
| 84 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.78219342 |
| 85 | branched-chain amino acid catabolic process (GO:0009083) | 2.77614690 |
| 86 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.77260642 |
| 87 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.75968484 |
| 88 | ATP synthesis coupled proton transport (GO:0015986) | 2.75968484 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74787495 |
| 90 | nuclear envelope reassembly (GO:0031468) | 2.74787495 |
| 91 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 2.74487103 |
| 92 | base-excision repair (GO:0006284) | 2.71885330 |
| 93 | establishment of viral latency (GO:0019043) | 2.70776911 |
| 94 | prostanoid biosynthetic process (GO:0046457) | 2.69074983 |
| 95 | prostaglandin biosynthetic process (GO:0001516) | 2.69074983 |
| 96 | ubiquinone biosynthetic process (GO:0006744) | 2.68526916 |
| 97 | tricarboxylic acid metabolic process (GO:0072350) | 2.67983326 |
| 98 | heme biosynthetic process (GO:0006783) | 2.67880705 |
| 99 | respiratory electron transport chain (GO:0022904) | 2.67778258 |
| 100 | GMP metabolic process (GO:0046037) | 2.63376054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.01113492 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.66776622 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18136219 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.08037367 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.87456583 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.76044633 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63082129 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59303756 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52015911 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20676792 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11593388 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.03667249 |
| 13 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.01395849 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99798739 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.99282906 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.97938380 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.95650790 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95026385 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93213496 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.92974087 |
| 21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87267742 |
| 22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.87238773 |
| 23 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.87096320 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86737142 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.85910867 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83520351 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81400896 |
| 28 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.80541491 |
| 29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.75835536 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.74745876 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72403591 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71108199 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70736628 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68619088 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64002233 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63822438 |
| 37 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.63136841 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.62471080 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61158538 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.59415214 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57549869 |
| 42 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.54984546 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50673369 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50099289 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49912277 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48784720 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48419825 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.47210242 |
| 49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46187873 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.45775582 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45658466 |
| 52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44649748 |
| 53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39842824 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37014334 |
| 55 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34593149 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34184226 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33726400 |
| 58 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.31153151 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29957193 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27856237 |
| 61 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27410318 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27098877 |
| 63 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26935751 |
| 64 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26810328 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25915493 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23844953 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22947519 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22108285 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21457134 |
| 70 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20822204 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19350507 |
| 72 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.17198760 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16636204 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16536064 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.15901061 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15600318 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14541199 |
| 78 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13242476 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12266997 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11937924 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11914728 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09003901 |
| 83 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07818261 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07619995 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06225183 |
| 86 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05615441 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05171500 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03846805 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02819251 |
| 90 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02572759 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01935363 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01909013 |
| 93 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98527800 |
| 94 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98492456 |
| 95 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98303652 |
| 96 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98269092 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96961054 |
| 98 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96636306 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96398724 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96118203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.99446114 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.83683519 |
| 3 | MP0005451_abnormal_body_composition | 3.37129825 |
| 4 | MP0003186_abnormal_redox_activity | 3.14214798 |
| 5 | MP0005360_urolithiasis | 2.96630195 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 2.74207951 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.73991665 |
| 8 | MP0009278_abnormal_bone_marrow | 2.63279366 |
| 9 | MP0004147_increased_porphyrin_level | 2.50602977 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.45618240 |
| 11 | MP0009697_abnormal_copulation | 2.41279968 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.38258890 |
| 13 | MP0009840_abnormal_foam_cell | 2.36858371 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.07760521 |
| 15 | MP0001764_abnormal_homeostasis | 2.01271857 |
| 16 | MP0005464_abnormal_platelet_physiology | 1.99080270 |
| 17 | MP0000681_abnormal_thyroid_gland | 1.93018130 |
| 18 | MP0008260_abnormal_autophagy | 1.92645792 |
| 19 | MP0010030_abnormal_orbit_morphology | 1.90400698 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88044416 |
| 21 | MP0002132_abnormal_respiratory_system | 1.84715894 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.73885172 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.73849764 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.68780807 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.68780807 |
| 26 | MP0008932_abnormal_embryonic_tissue | 1.63561985 |
| 27 | MP0001727_abnormal_embryo_implantation | 1.59137842 |
| 28 | MP0001881_abnormal_mammary_gland | 1.58151427 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57954117 |
| 30 | MP0000490_abnormal_crypts_of | 1.57782879 |
| 31 | MP0005332_abnormal_amino_acid | 1.56340520 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.56116622 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.55226730 |
| 34 | MP0004858_abnormal_nervous_system | 1.52476557 |
| 35 | MP0005670_abnormal_white_adipose | 1.49920803 |
| 36 | MP0005365_abnormal_bile_salt | 1.44899562 |
| 37 | MP0000358_abnormal_cell_content/ | 1.44889621 |
| 38 | MP0002822_catalepsy | 1.42714262 |
| 39 | MP0005165_increased_susceptibility_to | 1.41630750 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.38428701 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.38272150 |
| 42 | MP0000751_myopathy | 1.37919606 |
| 43 | MP0000343_altered_response_to | 1.34121041 |
| 44 | MP0003315_abnormal_perineum_morphology | 1.33601219 |
| 45 | MP0001905_abnormal_dopamine_level | 1.32158563 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.31949723 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.26693621 |
| 48 | MP0003111_abnormal_nucleus_morphology | 1.25675989 |
| 49 | MP0005083_abnormal_biliary_tract | 1.23713016 |
| 50 | MP0006035_abnormal_mitochondrial_morpho | 1.23134326 |
| 51 | MP0001529_abnormal_vocalization | 1.19573872 |
| 52 | MP0003075_altered_response_to | 1.19483078 |
| 53 | MP0005501_abnormal_skin_physiology | 1.18761932 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.18109989 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.10911698 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.09386948 |
| 57 | MP0005330_cardiomyopathy | 1.08836707 |
| 58 | MP0000858_altered_metastatic_potential | 1.07018291 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.05236896 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.03067829 |
| 61 | MP0000609_abnormal_liver_physiology | 1.01654738 |
| 62 | MP0000747_muscle_weakness | 1.01340116 |
| 63 | MP0001542_abnormal_bone_strength | 1.00805188 |
| 64 | MP0002234_abnormal_pharynx_morphology | 0.99040277 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 0.98928006 |
| 66 | MP0001661_extended_life_span | 0.95421175 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.94977961 |
| 68 | MP0003718_maternal_effect | 0.93970401 |
| 69 | MP0003786_premature_aging | 0.91504913 |
| 70 | MP0008469_abnormal_protein_level | 0.89564132 |
| 71 | MP0002970_abnormal_white_adipose | 0.89230257 |
| 72 | MP0000598_abnormal_liver_morphology | 0.85794656 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.85679480 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 0.85488284 |
| 75 | MP0000313_abnormal_cell_death | 0.85340071 |
| 76 | MP0009764_decreased_sensitivity_to | 0.84436633 |
| 77 | MP0001666_abnormal_nutrient_absorption | 0.84420598 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.83460986 |
| 79 | MP0008058_abnormal_DNA_repair | 0.82108105 |
| 80 | MP0002118_abnormal_lipid_homeostasis | 0.82077121 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.81508024 |
| 82 | MP0004233_abnormal_muscle_weight | 0.80170166 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.80123318 |
| 84 | MP0004957_abnormal_blastocyst_morpholog | 0.79071134 |
| 85 | MP0003077_abnormal_cell_cycle | 0.78718766 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 0.77879250 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.77592397 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 0.76108479 |
| 89 | MP0005499_abnormal_olfactory_system | 0.75341894 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.75341894 |
| 91 | MP0009763_increased_sensitivity_to | 0.73308850 |
| 92 | MP0005257_abnormal_intraocular_pressure | 0.73033995 |
| 93 | MP0005025_abnormal_response_to | 0.72705759 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.72559250 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.71904661 |
| 96 | MP0001664_abnormal_digestion | 0.69490423 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.65503552 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.63415935 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.63206653 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.62533410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ragged-red muscle fibers (HP:0003200) | 3.67762872 |
| 2 | Increased muscle lipid content (HP:0009058) | 3.59340373 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.56089820 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.49256845 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.46199201 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.46199201 |
| 7 | Increased intramyocellular lipid droplets (HP:0012240) | 3.41656851 |
| 8 | Hepatic necrosis (HP:0002605) | 3.31097787 |
| 9 | Dicarboxylic aciduria (HP:0003215) | 3.29480329 |
| 10 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.29480329 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.22486073 |
| 12 | Cholecystitis (HP:0001082) | 3.18665313 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.18665313 |
| 14 | Reticulocytopenia (HP:0001896) | 3.07314448 |
| 15 | Opisthotonus (HP:0002179) | 3.05879063 |
| 16 | Vertebral compression fractures (HP:0002953) | 3.04732835 |
| 17 | Mitochondrial inheritance (HP:0001427) | 2.99701902 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 2.95788348 |
| 19 | Increased serum pyruvate (HP:0003542) | 2.94383330 |
| 20 | Abnormality of glycolysis (HP:0004366) | 2.89976308 |
| 21 | Acute encephalopathy (HP:0006846) | 2.89773328 |
| 22 | Cerebral palsy (HP:0100021) | 2.88256626 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 2.83735412 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.80998028 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.80998028 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 2.80998028 |
| 27 | Hyperammonemia (HP:0001987) | 2.79246526 |
| 28 | Hypertensive crisis (HP:0100735) | 2.77345112 |
| 29 | Myoglobinuria (HP:0002913) | 2.75181482 |
| 30 | Exercise intolerance (HP:0003546) | 2.74570440 |
| 31 | Microvesicular hepatic steatosis (HP:0001414) | 2.70236622 |
| 32 | Petechiae (HP:0000967) | 2.66888022 |
| 33 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.66736332 |
| 34 | Hyperglycinemia (HP:0002154) | 2.65356011 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.64511684 |
| 36 | Increased CSF lactate (HP:0002490) | 2.57276546 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57080902 |
| 38 | Lactic acidosis (HP:0003128) | 2.56481482 |
| 39 | Prolonged neonatal jaundice (HP:0006579) | 2.51756635 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.47946802 |
| 41 | Cerebral edema (HP:0002181) | 2.44306359 |
| 42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.42188161 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42073056 |
| 44 | Abnormal number of erythroid precursors (HP:0012131) | 2.41570020 |
| 45 | Abnormal protein glycosylation (HP:0012346) | 2.37993292 |
| 46 | Abnormal glycosylation (HP:0012345) | 2.37993292 |
| 47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37993292 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37993292 |
| 49 | Achilles tendon contracture (HP:0001771) | 2.33554622 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.33205380 |
| 51 | Microretrognathia (HP:0000308) | 2.32854301 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30496056 |
| 53 | Abnormality of the Achilles tendon (HP:0005109) | 2.29728096 |
| 54 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29040340 |
| 55 | Myopathic facies (HP:0002058) | 2.24995980 |
| 56 | Abnormality of reticulocytes (HP:0004312) | 2.21914515 |
| 57 | Muscle stiffness (HP:0003552) | 2.21294154 |
| 58 | Increased serum lactate (HP:0002151) | 2.20603085 |
| 59 | Progressive neurologic deterioration (HP:0002344) | 2.18695383 |
| 60 | Progressive muscle weakness (HP:0003323) | 2.17449171 |
| 61 | Emotional lability (HP:0000712) | 2.14450272 |
| 62 | Obstructive lung disease (HP:0006536) | 2.13134764 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13134764 |
| 64 | Spastic paraparesis (HP:0002313) | 2.12411168 |
| 65 | Purpura (HP:0000979) | 2.07116447 |
| 66 | Respiratory failure (HP:0002878) | 2.06519979 |
| 67 | Hypokinesia (HP:0002375) | 2.06273421 |
| 68 | Broad distal phalanx of finger (HP:0009836) | 1.99517568 |
| 69 | Progressive microcephaly (HP:0000253) | 1.98947666 |
| 70 | Hyperthyroidism (HP:0000836) | 1.97633804 |
| 71 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96991226 |
| 72 | Lethargy (HP:0001254) | 1.96026520 |
| 73 | Abnormality of the umbilical cord (HP:0010881) | 1.95039928 |
| 74 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94751823 |
| 75 | Dysostosis multiplex (HP:0000943) | 1.92400614 |
| 76 | Multiple enchondromatosis (HP:0005701) | 1.90869588 |
| 77 | Thoracic kyphosis (HP:0002942) | 1.90518606 |
| 78 | Exercise-induced myalgia (HP:0003738) | 1.90029433 |
| 79 | Macrocytic anemia (HP:0001972) | 1.88848332 |
| 80 | Renal Fanconi syndrome (HP:0001994) | 1.88526849 |
| 81 | Fasciculations (HP:0002380) | 1.88481162 |
| 82 | Delayed CNS myelination (HP:0002188) | 1.86834828 |
| 83 | Progressive macrocephaly (HP:0004481) | 1.86183261 |
| 84 | J-shaped sella turcica (HP:0002680) | 1.85612307 |
| 85 | Esophageal neoplasm (HP:0100751) | 1.85273377 |
| 86 | Neoplasm of head and neck (HP:0012288) | 1.85273377 |
| 87 | Rough bone trabeculation (HP:0100670) | 1.85209479 |
| 88 | Abnormality of glycine metabolism (HP:0010895) | 1.85199810 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85199810 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 1.84681325 |
| 91 | Seborrheic dermatitis (HP:0001051) | 1.82531798 |
| 92 | Reticulocytosis (HP:0001923) | 1.81461914 |
| 93 | Epiphyseal stippling (HP:0010655) | 1.80146753 |
| 94 | Testicular atrophy (HP:0000029) | 1.78426555 |
| 95 | Truncus arteriosus (HP:0001660) | 1.77904550 |
| 96 | Atelectasis (HP:0100750) | 1.77415490 |
| 97 | Brushfield spots (HP:0001088) | 1.75881982 |
| 98 | Abnormality of the tricuspid valve (HP:0001702) | 1.74486101 |
| 99 | Trismus (HP:0000211) | 1.73818920 |
| 100 | Abnormal pupillary function (HP:0007686) | 1.73333928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.30137040 |
| 2 | NME2 | 4.04885295 |
| 3 | TESK2 | 3.86473752 |
| 4 | VRK2 | 3.69612171 |
| 5 | TESK1 | 3.45292547 |
| 6 | ERN1 | 3.18157902 |
| 7 | PIM2 | 2.96200913 |
| 8 | SCYL2 | 2.81399809 |
| 9 | MAP3K11 | 2.67091585 |
| 10 | KDR | 2.41042207 |
| 11 | ARAF | 2.39697129 |
| 12 | LIMK1 | 1.97186281 |
| 13 | PBK | 1.78951647 |
| 14 | TAOK2 | 1.73405253 |
| 15 | CDK19 | 1.72953502 |
| 16 | SMG1 | 1.62214151 |
| 17 | MAP2K3 | 1.56729836 |
| 18 | IRAK3 | 1.53272525 |
| 19 | ABL2 | 1.53078080 |
| 20 | EPHA2 | 1.49297480 |
| 21 | TRIB3 | 1.47732312 |
| 22 | TBK1 | 1.45720233 |
| 23 | FLT3 | 1.44959338 |
| 24 | DAPK1 | 1.40190480 |
| 25 | CSNK1G3 | 1.38374799 |
| 26 | MAP2K7 | 1.34330419 |
| 27 | CDC7 | 1.29806966 |
| 28 | CCNB1 | 1.28643937 |
| 29 | BUB1 | 1.27787444 |
| 30 | AURKA | 1.19642462 |
| 31 | MAP4K2 | 1.14252685 |
| 32 | LRRK2 | 1.11432747 |
| 33 | DYRK1B | 1.04343746 |
| 34 | CSNK1A1L | 1.03302633 |
| 35 | VRK1 | 1.01896467 |
| 36 | CDK8 | 1.00683354 |
| 37 | DAPK3 | 0.99098057 |
| 38 | CDK7 | 0.98472784 |
| 39 | STK16 | 0.93951777 |
| 40 | GRK6 | 0.86263297 |
| 41 | MAP3K12 | 0.86013904 |
| 42 | PAK4 | 0.84629955 |
| 43 | EPHB2 | 0.83537805 |
| 44 | NEK1 | 0.83347623 |
| 45 | MAP3K3 | 0.79780387 |
| 46 | RPS6KA4 | 0.79306423 |
| 47 | LMTK2 | 0.78724357 |
| 48 | MAP4K1 | 0.78593749 |
| 49 | CSNK1G1 | 0.77564344 |
| 50 | CSNK1G2 | 0.75264640 |
| 51 | ILK | 0.74100109 |
| 52 | RPS6KB2 | 0.73544749 |
| 53 | RPS6KA5 | 0.66565138 |
| 54 | AURKB | 0.65728498 |
| 55 | AKT2 | 0.64528714 |
| 56 | CDK14 | 0.64194293 |
| 57 | KIT | 0.63816411 |
| 58 | MAPKAPK3 | 0.62145263 |
| 59 | MAP3K6 | 0.61778583 |
| 60 | BRAF | 0.61506646 |
| 61 | CDK11A | 0.61015893 |
| 62 | ATR | 0.60679408 |
| 63 | SRPK1 | 0.59997969 |
| 64 | DYRK2 | 0.59716691 |
| 65 | CAMK2G | 0.59430966 |
| 66 | MAP3K8 | 0.58205657 |
| 67 | CHEK2 | 0.57361660 |
| 68 | MAP2K4 | 0.56486450 |
| 69 | MAP3K5 | 0.55396803 |
| 70 | CSF1R | 0.55313940 |
| 71 | MUSK | 0.54808605 |
| 72 | PAK1 | 0.54131597 |
| 73 | CDK15 | 0.51257617 |
| 74 | EIF2AK1 | 0.50131203 |
| 75 | TLK1 | 0.49802713 |
| 76 | MAPK11 | 0.49112655 |
| 77 | MOS | 0.45827146 |
| 78 | CDK9 | 0.45148385 |
| 79 | CDK18 | 0.45083710 |
| 80 | NME1 | 0.44979930 |
| 81 | PRPF4B | 0.44448065 |
| 82 | MYLK | 0.43999602 |
| 83 | MAP3K1 | 0.43062291 |
| 84 | CSNK2A2 | 0.41605450 |
| 85 | PKN2 | 0.40763035 |
| 86 | TYK2 | 0.40374129 |
| 87 | PLK1 | 0.39016964 |
| 88 | CSNK2A1 | 0.37503858 |
| 89 | RAF1 | 0.35137497 |
| 90 | SIK1 | 0.33509207 |
| 91 | JAK3 | 0.32472104 |
| 92 | MAP2K2 | 0.32137202 |
| 93 | CSNK1A1 | 0.28821809 |
| 94 | CDK4 | 0.27046526 |
| 95 | MST1R | 0.25755618 |
| 96 | MAP2K6 | 0.25669717 |
| 97 | RPS6KC1 | 0.24588823 |
| 98 | RPS6KL1 | 0.24588823 |
| 99 | IKBKB | 0.24472554 |
| 100 | PRKCI | 0.23465557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.36912669 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.27181490 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 3.04104194 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.96992119 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91345141 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.48921104 |
| 7 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.43778835 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.33588092 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.27522434 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.24537360 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.14529075 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.14510558 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.10782272 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.09735639 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.07664251 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03336885 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.97989314 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.94732004 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.78300753 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74144424 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67520452 |
| 22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56366198 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.55076155 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53825058 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52728384 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.52181629 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51841557 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50221707 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45762139 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45177875 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.44107513 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38369686 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37661762 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36677623 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31623372 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31564846 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29999080 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29973248 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26323506 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.25333181 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22074479 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19127408 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18209386 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17515027 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 1.15168484 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14640924 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13407741 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11448578 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06432787 |
| 50 | Metabolic pathways_Homo sapiens_hsa01100 | 0.98485147 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95522892 |
| 52 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95120848 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92060452 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91183763 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88446545 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88323795 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.88213004 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84586928 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83766973 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.82236805 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74703913 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72846037 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71404514 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70662229 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68477261 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67773080 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66722171 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 0.65876356 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62767412 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62596757 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60329911 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57189853 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56252122 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54806845 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51191378 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50291015 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50079498 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49578198 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45863871 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45487350 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45098120 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44571237 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41036614 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.39397129 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39198619 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.37766788 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.33177521 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32614851 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32392687 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31172842 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.28078560 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27043467 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25372060 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25318630 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24173917 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23530540 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23370691 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22621198 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22418900 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19648427 |

